PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Greystone Associates

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Global Injectable Drug Delivery Sector Examined in New Report - Device sophistication and design ergonomics providing new opportunities for branding according to Greystone Research Associates - GreystoneAssociates.org
Global Injectable Drug Delivery Sector Examined in New Report

 

NewswireToday - /newswire/ - Amherst, NH, United States, 2012/09/10 - Device sophistication and design ergonomics providing new opportunities for branding according to Greystone Research Associates - GreystoneAssociates.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The rapid evolution taking place within the injectable drug delivery sector – driven by biologicals and device technology advances – continues to effect changes throughout the supply chain and syringe/injector ecosystem. New classes of injection devices have opened the way to new forms of patient self-care, introducing a growing segment of consumers to parenteral drug self-administration. The changes are impacting the various device segments in different ways and to differing degrees.

The number of companies providing pre- and post fill/finish services to PFS suppliers and their drug developer partners continues to proliferate, due to the geographical nature of this business segment. For their part, PFS manufacturers, now primarily located in Europe, continue to establish syringe making facilities in strategic pharmaceutical and biotech regions, promoting the advantages of proximity and modern fabrication plant design. As they do, the supply chain follows, resulting in a spreading ecosystem with growing capabilities.

While the Pen injector supply market continues to be dominated by Ypsomed and a handful of other players, competition in this segment is growing, due to improvements in pen device design, reduced part counts and evolving state-of-the-art. On the therapeutic side, pens continue to dominate markets for insulin and hormone replacement. Pens are gaining ground in new therapeutic markets as a result of design wins for a number of recently approved drugs.

Leading suppliers of retractable safety syringes have made progress in lowering unit device cost, closing the gap between integrated safety syringes and adapted devices. The metamorphosis initiated by Unilife that is taking place with the convergence of safety and prefillable syringes, while still in its early stages, is expected to create opportunities for drug marketers by enabling the introduction of injectables that appeal to lay and professional users alike, while satisfying the need for caregiver safety.

Autoinjector designs continue to migrate toward disposables, creating branding opportunities for marketers and greater ease-of-use for patients. The evolution in autoinjector design is beginning to blur the distinction between pen injectors and autoinjector-enclosed prefilled syringes.

Recent progress in needle-free injector devices has come primarily from newer players pursuing niche markets. These companies are taking a page from the pen injector playbook, investing in tooling and technology to produce NFI devices that are esthetically pleasing and functionally advanced relative to previous generation NFIs

Detailed analysis of global injectable drug delivery markets is contained in a new and comprehensive report from Greystone. Injectable Drug Delivery to 2016: Drugs, Devices, Targets, Therapeutics and Forecasts documents and analyzes the results of a recent survey of injectable drug markets conducted by Greystone Research Associates.

About Greystone

Greystone Associates (greystoneassociates.org) is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Greystone Associates

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Global Injectable Drug Delivery Sector Examined in New Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mark Smith - GreystoneAssociates.org 
603-595-4340 mksmith[.]greystoneassociates.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Greystone Associates securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Greystone Associates / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)